Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ilya I. Afanasyev"'
Autor:
Natalya I. Vasilevich, Victor V. Tatarskiy, Elena A. Aksenova, Denis N. Kazyulkin, Ilya I. Afanasyev
Publikováno v:
Pharmaceuticals, Vol 9, Iss 2, p 19 (2016)
Based on the data for compounds known from the literature to be active against various types of Ser/Thr kinases, a general pharmachophore model for these types of kinases was developed. The search for the molecules fitting to this pharmacophore among
Externí odkaz:
https://doaj.org/article/e0ea096e19694f9398e19bfa0a5ce99b
Autor:
D. A. Mavletova, Natalya I. Vasilevich, D. A. Maslov, Olga B. Bekker, Ilya I. Afanasyev, Valery N. Danilenko, L M Kniazeva, M. G. Alekseeva
Publikováno v:
Bulletin of Russian State Medical University. :38-43
Publikováno v:
Proceedings of 2nd International Electronic Conference on Medicinal Chemistry.
Based on an earlier suggested general pharnacophore approach, compounds active against tuberculosis virulent strain H37Rv were obtained. The main drawback of these compounds was an almost complete CYP 3A4 inhibition, which presumably could be overcom
Publikováno v:
Proceedings of 1st International Electronic Conference on Medicinal Chemistry.
Based on the data of compounds known from the literature to be active against various types of Ser/Thr kinases a general pharmachophore model for these types of kinases was developed. Search for the molecules fitting to this pharmacophore among ASINE
Publikováno v:
Chemical biologydrug design. 88(1)
A general pharmachophore model for various types of Ser/Thr kinases was developed. Search for the molecules fitting to this pharmacophore among ASINEX proprietary library revealed a number of compounds, which were tested and appeared to possess some
Autor:
Ilya I. Afanasyev, Valery S. Kochubey, Natalya I. Vasilevich, Dmitry A. Kovalskiy, Dmitry V. Genis
Publikováno v:
Chemical biologydrug design. 84(5)
The general model of epitope-type MDM2 inhibitor was developed based on the structural information on the complexes between MDM2 and various low molecular weight ligands found in the PDB database. Application of this model to our in-house library has
Autor:
Denis N. Kazyulkin, Natalya I. Vasilevich, Elena Aksenova, Ilya I. Afanasyev, Victor V. Tatarskiy
Publikováno v:
Pharmaceuticals
Pharmaceuticals; Volume 9; Issue 2; Pages: 19
Pharmaceuticals, Vol 9, Iss 2, p 19 (2016)
Pharmaceuticals; Volume 9; Issue 2; Pages: 19
Pharmaceuticals, Vol 9, Iss 2, p 19 (2016)
Based on the data for compounds known from the literature to be active against various types of Ser/Thr kinases, a general pharmachophore model for these types of kinases was developed. The search for the molecules fitting to this pharmacophore among
Autor:
Eugene A. Rastorguev, Valery S. Kochubey, Ilya I. Afanasyev, Natalya I. Vasilevich, Dmitry V. Genis
Publikováno v:
MedChemComm. 4:1597
A new class of alpha-helix mimetics, based on the phenyl-pyrazole-phenyl (6-5-6) system, has been designed and synthesized. The ability of the new compounds to inhibit PPIs was confirmed using an MDM2-p53 binding assay. The library, containing comple
Autor:
Masalceva AA; Faculty of Physics, Lomonosov Moscow State University, Moscow, Russia; Center for Theoretical Problems of Physico-chemical Pharmacology, Russian Academy of Science, Moscow, Russia., Kaneva VN; Faculty of Physics, Lomonosov Moscow State University, Moscow, Russia; Center for Theoretical Problems of Physico-chemical Pharmacology, Russian Academy of Science, Moscow, Russia; Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia., Panteleev MA; Faculty of Physics, Lomonosov Moscow State University, Moscow, Russia; Center for Theoretical Problems of Physico-chemical Pharmacology, Russian Academy of Science, Moscow, Russia; Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia; Faculty of Biological and Medical Physics, Moscow Institute of Physics and Technology, Dolgoprudnyi, Russia., Ataullakhanov F; Faculty of Physics, Lomonosov Moscow State University, Moscow, Russia; Center for Theoretical Problems of Physico-chemical Pharmacology, Russian Academy of Science, Moscow, Russia; Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia; Faculty of Biological and Medical Physics, Moscow Institute of Physics and Technology, Dolgoprudnyi, Russia., Volpert V; Institut Camille Jordan, UMR 5208 CNRS, University Lyon 1, 69622 Villeurbanne, France; INRIA Team Dracula, INRIA Lyon La Doua, 69603 Villeurbanne, France; Peoples' Friendship University of Russia (RUDN University), 6 Miklukho-Maklaya St, Moscow 117198, Russia., Afanasyev I; Moscow Center of Fundamental and Applied Mathematics, Moscow, Russia; Research Computing Center of Moscow State University, Moscow, Russia., Nechipurenko DY; Faculty of Physics, Lomonosov Moscow State University, Moscow, Russia; Center for Theoretical Problems of Physico-chemical Pharmacology, Russian Academy of Science, Moscow, Russia; Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia. Electronic address: ne4ipur@gmail.com.
Publikováno v:
Journal of biomechanics [J Biomech] 2022 Jan; Vol. 130, pp. 110801. Date of Electronic Publication: 2021 Oct 09.